You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Moodys
Harvard Business School
Colorcon
McKesson

Last Updated: February 23, 2020

DrugPatentWatch Database Preview

Litigation Details for HORIZON PHARMA AG v. PAR PHARMACEUTICAL COMPANIES, INC. (D.N.J. 2013)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

HORIZON PHARMA AG v. PAR PHARMACEUTICAL COMPANIES, INC. (D.N.J. 2013)

Docket   Start Trial Date Filed 2013-10-22
Court District Court, D. New Jersey Date Terminated 2013-12-06
Cause 35:271 Patent Infringement Assigned To Joseph Eron Irenas
Jury Demand None Referred To Joel Schneider
Parties HORIZON PHARMA AG; JAGOTEC AG; PAR PHARMACEUTICAL COMPANIES, INC.; PAR PHARMACEUTICAL, INC.
Patents 6,488,960; 6,677,326; 8,168,218
Attorneys GINA R. GENCARELLI; JOHN F. BRENNER; MELISSA ANNE CHUDEREWICZ
Firms Latham and Watkins LLP; Pepper Hamilton LLP
Link to Docket External link to docket
Small Molecule Drugs cited in HORIZON PHARMA AG v. PAR PHARMACEUTICAL COMPANIES, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for HORIZON PHARMA AG v. PAR PHARMACEUTICAL COMPANIES, INC. (D.N.J. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-10-22 1 Statcs Patent Nos. 6.488.960 [“lhe `960 patent"). 616??.326 ("'the `326 patent"). …l FOR INFRINGEMENT ()F U.S. PATEN'I" 6,488,960 29. l’laintiffs reallege and incorporate by reference… infringed one or more claims of Ll.S. Patcnt 6.488,960: B. A judgment declaring that Del`endants have… 'I`his is an action for patent infringement arising under the patent laws of the United Slates, Til….218 ("`the `218 patent"), and 8._394,40? (_"the "40? patent") which cover l External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Express Scripts
Harvard Business School
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.